top
Search terms
Results 1 - 10 of 51 - ordered by :
Pages: 1 2 3 4 5 6 ... 6
Ejhf

In this issue of the journal, Cannon et al. show the protective effects of the new, high-affinity, liver X factor receptor agonist, AZ876, on pathological cardiac hypertrophy and fibrosis in an ...

European Journal of Heart Failure, Metra, Marco

Date : 01/03/2015 Item size : 73275 bytes
Ehjcardiovascrec

An expanding body of evidence indicates that certain dietary patterns can influence cardiovascular health and primary prevention of CVD by modifying risk factors such as obesity, dyslipidemia, and ...

Cardiovascular Research, Editorial, Claudio Napoli, William C. Stanley, Louis J. Ignarro

Date : 15/01/2007 Item size : 226859 bytes
Ehjcardiovascrec

Animal as well as human studies have shown beneficial changes in biological phenomena related to cardiovascular health after the consumption of polyphenol-rich foods such as cocoa, red wine, tea, and ...

Cardiovascular Research, Editorial, José A. Páramo

Date : 01/07/2008 Item size : 165875 bytes
Ehjcardiovascrec

In addition to their lipid-lowering effects, one central biological action of statins is their ability to ameliorate the impaired bioavailability of NO.1 Mechanistically, this occurs through ...

Cardiovascular Research, Editorial, Stephan H. Schirmer, Christian M. Werner, Ulrich Laufs, Michael Böhm

Date : 01/06/2012 Item size : 181712 bytes
AnatolianJournal

Use of aspirin in patients taking angiotensin converting enzyme inhibitors Timuçin Altýn1, Mustafa Kýlýçkap1 Ankara Üniversitesi Týp Fakültesi, Kardiyoloji Anabilim Dalý, ...

Date : 12/01/2017 Item size : 33364 bytes
Ehjcardiovascrec

In patients with coronary artery disease (CAD), endothelial dysfunction results in abnormal coronary artery vasomotion, increased leucocyte adhesion to the vascular wall, platelet activation, and the ...

Cardiovascular Research, EDITORIALS: SPOTLIGHT ON LANDMARK PAPERS IN, Juan Carlos Kaski, Luciano Consuegra-Sanchez

Date : 01/11/2012
Ehjcardiovascrec

Abstract Aims Valsartan, a selective angiotensin II type 1 receptor (AT1R) blocker, has beneficial effects in the cardiovascular system in part by its increase of nitric oxide (NO) bioavailability, ...

Cardiovascular Research, Original Article, Kuo-Hui Su, Jin-Yi Tsai, Yu Ru Kou, An-Na Chiang, Sheng-Huang Hsiao, Yuh-Lin Wu, Hsin-Han Hou, Ching-Chian Pan, Song-Kun Shyue, Tzong-Shyuan Lee

Date : 01/06/2009
Ehjcardiovascrec

In one clinical trial, 4444 patients were carefully studied and not only was simvastatin shown to be safe and effective in lowering circulating cholesterol, it also significantly improved survival in ...

Cardiovascular Research, Review, Allan M Lefer, Rosario Scalia, David J Lefer

Date : 01/02/2001
Ehjcardiovascrec

Abstract Aims The requirement of endothelial NO synthase (NOS3) calcium to produce NO is well described, although the effect of NO on intracellular calcium levels [Ca2+]i is still confusing. [...]NO ...

Cardiovascular Research, Original Article, Emeline Perrier, Marie-Pierre Fournet-Bourguignon, Emilie Royere, Stephanie Molez, Helene Reure, Ludovic Lesage, Willy Gosgnach, Yves Frapart, Jean-Luc ...

Date : 01/04/2009
Ehjcardiovascrec

[11] (pages 130135) in this issue. 1 Introduction A widely accepted risk factor for the development of coronary artery disease is an elevated level of plasma cholesterol. Synthetic derivatives of ...

Cardiovascular Research, Editorial, Steven J Miller

Date : 01/10/2001